Ramsay Health Care Ltd
ASX:RHC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/FCFE
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Valuation Scenarios
If P/FCFE returns to its 3-Year Average (11.8), the stock would be worth AU$36.45 (5% downside from current price).
| Scenario | P/FCFE Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 12.4 | AU$38.27 |
0%
|
| 3-Year Average | 11.8 | AU$36.45 |
-5%
|
| 5-Year Average | 7.7 | AU$23.63 |
-38%
|
| Industry Average | 38.4 | AU$118.52 |
+210%
|
| Country Average | 18.1 | AU$55.77 |
+46%
|
Forward P/FCFE
Today’s price vs future free cash flow to equity
Peer Comparison
| Market Cap | P/FCFE | P/E | ||||
|---|---|---|---|---|---|---|
| AU |
|
Ramsay Health Care Ltd
ASX:RHC
|
9B AUD | 12.4 | 32.2 | |
| US |
|
HCA Healthcare Inc
NYSE:HCA
|
96.8B USD | 10.5 | 14.3 | |
| SA |
|
Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
|
98B SAR | 93.8 | 40.8 | |
| ZA |
N
|
Netcare Ltd
JSE:NTC
|
23.7B ZAR | 14.5 | 14.1 | |
| MY |
I
|
IHH Healthcare Bhd
KLSE:IHH
|
77.9B MYR | 34.4 | 37.1 | |
| ZA |
L
|
Life Healthcare Group Holdings Ltd
JSE:LHC
|
17.7B ZAR | 9.5 | 4.6 | |
| BR |
|
Rede D'Or Sao Luiz SA
BOVESPA:RDOR3
|
84.7B BRL | 107.3 | 18.1 | |
| US |
|
Tenet Healthcare Corp
NYSE:THC
|
15.9B USD | 9.4 | 11.4 | |
| CN |
A
|
Aier Eye Hospital Group Co Ltd
SZSE:300015
|
100.5B CNY | 24.1 | 29.8 | |
| IN |
|
Apollo Hospitals Enterprise Ltd
NSE:APOLLOHOSP
|
1.1T INR | 43.2 | 60.8 | |
| US |
|
Ensign Group Inc
NASDAQ:ENSG
|
10.7B USD | 29.2 | 30.7 |
Market Distribution
| Min | 0.2 |
| 30th Percentile | 12.5 |
| Median | 18.1 |
| 70th Percentile | 35.6 |
| Max | 5 049.1 |
Other Multiples
Ramsay Health Care Ltd
Glance View
Ramsay Health Care Ltd, a behemoth in the healthcare sector, sprouted from humble beginnings in a small Australian town, eventually unfolding its reach across the globe. Founded by Paul Ramsay in 1964, the company has grown to become one of the largest private hospital operators worldwide. It runs a vast network of hospitals, day surgery centers, and primary care facilities, welcoming millions of patients through its doors annually. Operating in markets like Australia, Europe, and parts of Asia, Ramsay thrives on the essential and ever-growing demand for quality healthcare services. The company focuses not only on delivering acute care but also engages in multidisciplinary medical and surgical treatments, serving as a critical backbone supporting public health systems straining under demand pressures. Ramsay Health Care generates its revenue primarily through patient services, the bulk of which comes from hospital admissions, procedures, and ancillary services such as physiotherapy and pharmacy operations. The company has strategically positioned itself in the private healthcare sector, catering to those willing or necessitated to utilize its vast array of medical services when public system waiting times are unavoidably long. Furthermore, it derives additional income through partnerships and joint ventures, bolstering its capability to offer specialized treatments and research initiatives. By continually expanding and optimizing its healthcare facilities, investing in state-of-the-art technology, and maintaining high standards of patient care, Ramsay aims to capitalize on global demographic trends such as aging populations and increasing chronic disease prevalence. Through these strategic endeavors, Ramsay Health Care ensures it remains a vital player in the global health arena, attuned to both clinical advancements and regional health policy changes.